High resolution anal examination for HPV and anal cancer detection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on individuals who have undergone high-resolution anoscopy (HRA) to screen for high-risk human papillomavirus (HPV) and anal squamous cell carcinoma (SCC). It aims to collect and analyze data related to HPV infection and its link to anal pathology, particularly in high-risk populations. The study will utilize anal swabs for cytology and HPV detection, with referrals for HRA recommended for those with abnormal results. By examining this data, the researchers hope to answer critical clinical questions and enhance understanding of anal cancer prevention and treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients who have undergone HRA and all future patients referred for HRA in UZ Brussel
* 18 years or older
* Understands and able to speak and write in French, Dutch or English

Exclusion Criteria:

* None

Where it's running

• UZ Brussel
  Jette, Belgium Recruiting

Study contacts

• Study coordinator: Magali Surmont
• Email: magali.surmont@uzbrussel.be
• Phone: +32 2 477

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Retifanlimab after chemoradiation for anal cancer

  This study tests whether retifanlimab can help people with anal squamous cell carcinoma who have completed chemoradiation and still have residual disease.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07927998

• HPV self-sampling in the ED to screen under-screened women

  This study tests whether giving an HPV self-sampling kit in the emergency department can help under-screened women get screened for cervical cancer and find those with HPV to guide follow-up care.

  Recruiting Rutgers, The State University of New Jersey · New Brunswick, New Jersey and 1 other locations · NCT07657104

• CHW4CervixHealth: HPV self-collection kits with community health workers

  This project will test whether giving self-collection HPV kits during community workshops led by community health workers helps increase screening among under-screened women aged 25–65 and will first compare kit results to clinical Pap smears.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07336134

• Preventing cervical cancer with rapid HPV genotyping and same-day self-sampling

  This project tests whether a rapid HPV genotyping test on self-collected and provider-collected samples can quickly identify women at high risk so they can receive same-day screening and treatment in low-resource settings.

  Recruiting at 4 sites Atila Biosystems Inc. · Sunnyvale, California and 3 other locations · NCT07232355

• EVOLVE104 for advanced bladder and other squamous cell cancers

  This will try EVOLVE104, an experimental drug, in adults with advanced or metastatic bladder or other squamous cell cancers who have already tried or cannot take standard treatments.

  Recruiting at 16 sites Phase 1 EvolveImmune United, Inc · Duarte, California and 15 other locations · NCT07217171

• Lidocaine injection before surgery for oropharyngeal cancer

  This study tests if giving a lidocaine injection before surgery can help improve outcomes for patients with oropharyngeal cancer.

  Recruiting Phase 1 Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania · NCT06747390

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.